Aragon Pharmaceuticals
About:
Aragon Pharmaceuticals develops therapeutics for the treatment of hormone-resistant cancers such as prostate and breast cancer.
Website: http://www.aragonpharmaceuticals.com
Top Investors: OrbiMed, The Column Group, venBio Partners, Aisling Capital, Topspin Partners
Description:
Aragon Pharmaceuticals is a discovery-stage small molecule company focused on therapeutics for the treatment of hormone-resistant cancers, with an initial focus on prostate and breast cancer.
Total Funding Amount:
$122M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
San Diego, California, United States
Founded Date:
2009-01-01
Contact Email:
info(AT)aragonpharmaceuticals.com
Founders:
Richard Heyman
Number of Employees:
11-50
Last Funding Date:
2012-10-04
IPO Status:
Private
Industries:
© 2025 bioDAO.ai